Biotech | May 10, 2022
Bora Pharmaceuticals acquires Eden Biologics CDMO assets
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
The expansion makes Exothera one of the largest viral vector facilities in Europe
Building the future of food in the birthplace of cell-cultured milk
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
Subscribe To Our Newsletter & Stay Updated
